Guardian Pharmacy Services (NYSE:GRDN) Issues Quarterly Earnings Results, Misses Expectations By $2.19 EPS

Guardian Pharmacy Services (NYSE:GRDN) posted its quarterly earnings results on Tuesday. The company reported ($2.00) EPS for the quarter, missing the consensus estimate of $0.19 by ($2.19), Zacks reports. The business had revenue of $314.39 million for the quarter, compared to the consensus estimate of $303.21 million. Guardian Pharmacy Services updated its FY 2024 guidance to EPS.

Guardian Pharmacy Services Stock Performance

NYSE:GRDN traded down $0.13 during mid-day trading on Friday, reaching $20.87. 29,617 shares of the stock were exchanged, compared to its average volume of 155,931. Guardian Pharmacy Services has a 1 year low of $14.16 and a 1 year high of $23.05.

Insider Buying and Selling at Guardian Pharmacy Services

In related news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were purchased at an average price of $14.00 per share, with a total value of $499,996.00. Following the completion of the acquisition, the director now directly owns 35,714 shares in the company, valued at $499,996. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Analyst Upgrades and Downgrades

GRDN has been the subject of a number of analyst reports. Stephens began coverage on shares of Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 target price for the company. Raymond James began coverage on Guardian Pharmacy Services in a research report on Monday, October 21st. They set an “outperform” rating and a $21.00 price objective for the company. Finally, Truist Financial raised their target price on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.